ESR1 and breast cancer: It has previously been demonstrated that TDRD3 can act as a co-activator of estrogen-mediated transcription15, therefore, we examined whether alteration of TDRD3 expression in estrogen receptor positive (ER+) MCF7 breast cancer cells may affect cell proliferation26.